Congress and the FDA are pushing pharmaceutical companies to replace animals with technology for drug research. That’s a long way off, but startups and industry stalwarts are working to make it happen.

Paris, France, Cambridge, USA, April 2nd, 2025 – TISSIUM, a privately-owned medtech company developing biomorphic programmable polymers for tissue reconstruction, is proud to unveil clinical data which were presented at the IFSSH Congress in Washington, D.C. on March 27, 2025, demonstrating the potential of its COAPTIUM® CONNECT System, an innovative atraumatic sutureless solution for peripheral nerve repair.
Peripheral nerve injuries pose a significant burden, often resulting in impaired nerve function, reduced dexterity, and decreased quality of life. Traditional microsurgical repair with sutures, while effective, presents challenges such as inconsistent functional recovery and the potential for additional nerve trauma. The need for disruptive technologies in nerve repair is clear—TISSIUM’s COAPTIUM® CONNECT System offers an innovative atraumatic sutureless method for coaptation of severed nerves.
Study Overview & Key Findings
A prospective, single-arm study was conducted in patients with digital nerve injuries to assess the COAPTIUM® CONNECT System. The trial enrolled 12 patients, of whom 10 completed the entire 1-year follow-up duration.
The Dutch chip equipment manufacturer will be exempted from the new US tariffs, allowing chipmakers like TSMC and Samsung easy access to lithography machines in America.
Well, the US and EU recently concluded on a trade deal, setting the tariff rates to the “baseline” 15% figure, along with potential ‘hundreds of billions’ in investments by the EU into America’s energy sector. However, there are tariff exemptions with specific categories, and one of them includes semiconductors, according to a statement released by the European Commission. This means that US companies could import chip equipment and essentials into the nation without paying the extra costs to the government in form of tariffs, and this means great news for the likes of Samsung and TSMC.
Is Chief Executive Officer and Chairman of the Board of BioStem Technologies (https://biostemtechnologies.com/), a leading innovator focused on harnessing the natural properties of perinatal tissue in the development, manufacture, and commercialization of allografts for regenerative therapies.
Jason brings a wealth of experience in strategic operations planning and technical projects management from his rigorous technical background. His diverse expertise includes continuous process improvement, training and development programs, regulatory compliance and best practices implementation, and advanced problem solving.
Jason began his career as a technical engineer working for Adecco at SC Johnson in 2009, where he developed comprehensive maintenance plans to support manufacturing processes at scale. He then transitioned to manufacturing and quality engineering for major organizations, including ATI Ladish Forging, Nemak, and HUSCO International, where he spearheaded process design and implementation, solved complex supply-chain and manufacturing problems, and improved product sourcing and purchasing.
Jason’s philanthropic work with the Juvenile Diabetes Research Foundation sparked an interest in biotech, leading him to co-found Biostem Technologies in 2014. As CEO he has leveraged his expertise to optimize tissue sourcing, strategically build out a 6,000 square foot tissue processing facility that is fully compliant with FDA 210,211, 1,271, and AATB standards, and put together an expert team of professionals to support the company’s continued growth.
Jason holds a B.S. in Mechanical Engineering Technology and a minor in Mathematics from the Milwaukee School of Engineering and is Six Sigma Black Belt certified. He also serves as a Processing and Distribution Council Member for the American Association of Tissue Banks (AATB), as well as serves as a member of the Government Affairs committee for BioFlorida.
#JasonMatuszewski #BioStemTechnologies #PerinatalTissue #RegenerativeTherapies #ChronicWounds #DiabeticFootUlcers #VenousUlcers #PressureUlcers #AmnioticTissue #TissueAllografts #ExtracellularMatrix #ECM #GrowthFactors #Cytokines #Collagen #ProgressPotentialAndPossibilities #IraPastor #Podcast #Podcaster #ViralPodcast #STEM #Innovation #Technology #Science #Research
BELLEVUE, Wash. — Quantum physics and outer space may seem as different as two tech frontiers can be, but the challenges facing Pacific Northwest ventures that are aiming to make their fortune on those frontiers are surprisingly similar.
Amid the current turbulence on the national political scene, it’s getting harder to capture the attention — and gain the support — of the federal government, which has historically been the leading funder of research and development. And that means it’s more important than ever for researchers, industry leaders and local officials to join forces.
“Think of it as a triad,” said Jason Yager, executive director of the Montana Photonics and Quantum Alliance, which is one of the beneficiaries of a $41 million Tech Hub grant awarded by the federal government a year ago. “If all of these pieces are working together, then where they meet is socio-economic growth, and then you’re ready to bring in the additional funding to launch that.”
In a world where families are limited to one child due to overpopulation, a set of identical septuplets must avoid being put to a long sleep by the government and dangerous infighting while investigating the disappearance of one of their own.
Our team strives to create quality recaps of your favorite films. On the channel, you will find stories about movies in Sci-Fi, thriller, fantasy, horror, drama, fiction, trash, comedy, detective, psychological thriller, and dystopia genres. Each video will intrigue you with surprises and mystery. Leave the names of your favorite movies in the comments, and we will make an exciting review about each of them.
We will be very grateful if you give us a like for our efforts and subscribe to the channel so as to not miss the next entertaining video. Thank you for watching our recap.
#movierecap #spoilerlab
Last month, Japanese startup foundry Rapidus began prototyping 2-nanometer gate-all-around (GAA) transistors at its new facility, a key step toward ramping up its first production in 2027.
The foundry, which aims to compete with TSMC and Samsung in leading-edge chips for AI, said in a press statement that in about three years, it has reached target milestones, including the fab groundbreaking in September 2023, clean room completion in 2024, and, in June this year, the installation of production equipment.
Rapidus and TSMC are two chipmakers that the Japanese government is relying on to revive the nation’s declining semiconductor industry. Rapidus, if successful, will make leading-edge 2-nm chips for companies like IBM. TSMC is producing 12-to 28-nanometer chips for image sensors and automotive applications at its base in Kumamoto, Japan.